NR3C1 and type 2 diabetes mellitus: Rodent studies suggest that modulation of glucocorticoid receptor activation may influence hepatic triglyceride accumulation (20, 23, 32) and the development of nonalcoholic fatty liver disease (NAFLD), a common feature in Type 2 diabetes (42).